Sai Parenteral’s IPO Subscription Status

Sai Parenteral’s IPO subscription status started on Tuesday March 24, 2026 and will close on March 27, 2026. Sai Parenteral’s IPO to raise around ₹409 crores via IPO. The retail quota is 35%, QIB is 50%, and NII is 15%. The price band is fixed at ₹372 to ₹392 per equity share.

Sai Parenteral’s IPO

The Sai Parenteral’s IPO minimum market lot is 38 shares with ₹14,896 application amount. The Sai Parenteral’s IPO is a Mainboard IPO, and it is to be listed on BSE, NSE.

Business Overview

Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.

Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.


IPOWatch View

We recommend investors may apply for an IPO with Long-term Views. Investors should also look at the QIB, NII, and Retail numbers before investing.

Sai Parenteral’s IPO Subscription Status – Day 1

CategoryDay 1Day 2Day 3
QIB0.000.000.00
NII0.000.000.00
bNII0.000.000.00
sNII0.000.000.00
RII0.000.000.00
Total0.000.000.00


Sai Parenteral’s IPO Investor Categories

  • Qualified Institutional Buyers (QIB): Financial Institutions, Banks, FIIs, and Mutual Funds
  • Non-Institutional Investors(NII): Individual Investors, NRIs, Companies, Trusts, etc
  • Retail Individual Investors (RII): Retail Individual Investors or NRIs
  • Employee (EMP): Eligible Employees
  • Others: Eligible Shareholders

Sai Parenteral’s IPO Review and Rating

  • Neutral
  • 2 ⭐⭐

Sai Parenteral’s IPO Form

How to apply for the Sai Parenteral’s IPO? You can apply for Sai Parenteral’s IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Sai Parenteral’s IPO in the Invest section. The other option is you can apply for Sai Parenteral’s IPO via IPO forms downloaded online. Check out the Asston Pharmaceuticals forms – Click IPO Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Sai Parenteral’s IPO Subscription Status FAQs:


When Sai Parenteral’s IPO Subscription will start?

The IPO subscription starts on March 24, 2026 for QIB, NII, and Retail Investors.

How to subscribe Sai Parenteral’s IPO?

You can go with ASBA and Non-ASBA options for a subscription. Go to your bank account and apply for IPO online via ASBA or download the form online or get the physical form and submit the filled form to your broker or bank.

How do I check live Sai Parenteral’s IPO Subscription Numbers Today?

One can visit our portal for live IPO subscription numbers that we are updating hourly basis from the official websites. One can check the live subscription on official websites on the particular IPO page.

How to Apply the Sai Parenteral’s IPO through Zerodha?

Log in to Console in Zerodha Website or in Application. Go to Portfolio and Click on IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Zerodha.

How to Apply the Sai Parenteral’s IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals “. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.

How to Apply the Sai Parenteral’s IPO through Paytm Money?

Log in to Paytm Money Application with your credentials. Select the IPO. You will see the IPO Name “Asston Pharmaceuticals ” Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Paytm Money.

Table of Contents

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *